Tuesday, May 2, 2023
12:03 PM EST – Clearmind Medicine Inc : Announced an agreement with IMP Clinical Supply Services. IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites. IMP is known for its comprehensive, tailor-made clinical supply services that address all study requirements. The array of services to be performed are fully compliant with GMP, GCP, and GDP standards. Clearmind Medicine Inc (C.CMND) shares were -$0.03 at 0.75.
Stocks in Play: Clearmind Medicine Inc , Tue, 02 May 2023 12:12:07 EST